AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,345,607 | -12.6% | 94,772 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $2,683,943 | +33.5% | 94,772 | +8.3% | 0.01% | +28.6% |
| Q1 2023 | $2,010,748 | -11.4% | 87,538 | +8.3% | 0.01% | -22.2% |
| Q4 2022 | $2,268,724 | -7.1% | 80,795 | -6.4% | 0.01% | -10.0% |
| Q3 2022 | $2,442,000 | -4.2% | 86,349 | -1.4% | 0.01% | +25.0% |
| Q1 2022 | $2,549,000 | +5.5% | 87,567 | +19.2% | 0.01% | +14.3% |
| Q4 2021 | $2,415,000 | -16.7% | 73,486 | +17.0% | 0.01% | -22.2% |
| Q3 2021 | $2,898,000 | +16.9% | 62,806 | +39.7% | 0.01% | +12.5% |
| Q2 2021 | $2,478,000 | +13.2% | 44,961 | +6.0% | 0.01% | 0.0% |
| Q1 2021 | $2,189,000 | -16.7% | 42,398 | -30.1% | 0.01% | -11.1% |
| Q4 2020 | $2,627,000 | +30.5% | 60,622 | +5.4% | 0.01% | +12.5% |
| Q3 2020 | $2,013,000 | -18.0% | 57,525 | +25.3% | 0.01% | -20.0% |
| Q2 2020 | $2,456,000 | +8.1% | 45,926 | -28.3% | 0.01% | -9.1% |
| Q1 2020 | $2,272,000 | -25.7% | 64,028 | 0.0% | 0.01% | -8.3% |
| Q4 2019 | $3,057,000 | +85.4% | 64,028 | +25.8% | 0.01% | +100.0% |
| Q3 2019 | $1,649,000 | – | 50,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |